REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 168 filers reported holding REGENXBIO INC in Q3 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $319,000 | +13.9% | 8,200 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $280,000 | -25.7% | 8,200 | -1.4% | 0.00% | -40.0% |
| Q4 2020 | $377,000 | +64.6% | 8,320 | 0.0% | 0.01% | +66.7% |
| Q3 2020 | $229,000 | -84.6% | 8,320 | -79.4% | 0.00% | -85.7% |
| Q2 2020 | $1,485,000 | +13.7% | 40,320 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $1,306,000 | -17.0% | 40,320 | 0.0% | 0.02% | +31.2% |
| Q4 2019 | $1,573,000 | +7.9% | 40,320 | -1.5% | 0.02% | 0.0% |
| Q3 2019 | $1,458,000 | -30.7% | 40,945 | 0.0% | 0.02% | -30.4% |
| Q2 2019 | $2,104,000 | -12.5% | 40,945 | -2.4% | 0.02% | -11.5% |
| Q1 2019 | $2,404,000 | +36.6% | 41,945 | 0.0% | 0.03% | +13.0% |
| Q4 2018 | $1,760,000 | -44.4% | 41,945 | 0.0% | 0.02% | -23.3% |
| Q3 2018 | $3,167,000 | – | 41,945 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
| Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
| ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
| Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
| Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
| RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
| WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
| HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
| Atom Investors LP | 36,487 | $901,000 | 0.39% |